Veteran's Perceptions of Ketamine-Assisted Psychotherapy for Depression and End-of-Life
Part of paid clinical trials in Albany, New York.
- Sponsor
- Albany Research Institute, Inc.
- Study ID
- NCT06824532
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 65 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
The goal of this exploratory, mixed-method design study is to gather qualitative and quantitative data obtained through interviews and questionnaires with veterans who are currently enrolled at the VA for healthcare. The main question this study aims to answer is: How do veterans aged 65+ who are enrolled for care at the VA understand ketamine assisted psychotherapy for depression and for end-of-life distress? Using a story-completion approach, participants will be provided with a brief story starter involving a fictitious character and scenario and asking them to complete the story. Few contextual details will be offered about the character. In responding to ambiguous cues, participants are thought to project their conscious and subconscious perceptions about the phenomenon in question onto the story, a useful method for exploring stigmatized topics. The purpose of this exercise is to ascertain the participants attitudes and perceptions regarding ketamine assisted psychotherapy.
Key Dates
- Start date
- Nov 8, 2024
- Status verified
- Feb 2025
- Primary completion
- Mar 31, 2025
- Completion
- Apr 30, 2025
Study Design
- Enrollment
- 30 participants (estimated)
Primary Outcome Measure
Patient Health Questionnaire 9 [ Time Frame: 2 weeks ]
Central Contacts
- Caitlin Holley, Ph.D.518-626-5365
- Stacey Farmer, Ph.D.518-798-6066
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Stratton VA Medical Center | Albany | New York | 12208 |
Find similar trials in Albany, NY
Related Studies
- Lay-Delivered Behavioral Activation in Senior CentersRecruiting · University of Washington · Brandon, Florida
- Safe Mothers, Safe Children InitiativeRecruiting · New York University · New York, New York
- A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.PHASE3 · Recruiting · AbbVie · Bentonville, Arkansas
- Accelerated TMS for Depression and OCDRecruiting · Weill Medical College of Cornell University · New York, New York